Safety and Immunogenicity of CJCV2 With and Without ALFQ
Clinical trial NCT05500417 · COMPLETED
Trial details
- NCT number
- NCT05500417
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2025-01-02
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.